Tuesday May 13, 2025
HE
NEWSLETTER
www.israelhayom.com
  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home Tidbits

Cost of HIV prevention injection expected to go from $42,250 to around $40

Over 42 million people have died from AIDS since its emergence, and around 40 million people live with HIV globally.

by  Alchemiq
Published on  07-24-2024 12:30
Last modified: 07-24-2024 11:37
HIV prevention injectionIsrael Hayom

HIV prevention injection | Photo: Israel Hayom

Share on FacebookShare on Twitter

Gilead Sciences' injectable HIV prevention drug Lenacapavir, also known as Sunlenca, showed promising results in late-stage trials, providing 100% protection to over 5,000 high-risk women in South Africa and Uganda. It requires only two injections per year instead of daily pills, making it easier to administer, particularly among high-risk groups.

While currently priced at around $42,250 per patient annually, researchers estimate that a generic version of Lenacapavir could reduce the cost to around $40 per year, based on raw material prices and discussions with manufacturers in China and India, making it more accessible globally, especially in low- and middle-income countries (LMICs).

Gilead is considering strategies to enable global access to Lenacapavir, potentially through voluntary licensing partners, and has been in talks with various organizations to ensure broader access for HIV treatment and prevention. The company has not disclosed the pricing or availability of generic versions in developing countries.

Winnie Byanyima, the executive director of the Joint United Nations Programme on HIV/AIDS (UNAIDS), urged Gilead to allow generic manufacturing of the drug to ensure broad access in developing countries.

Despite advances in HIV treatment and prevention, millions still live with and die from AIDS.

Researchers have used gene editing techniques like CRISPR to eradicate HIV from infected cells, aiming for a total virus eradication in the body, which could potentially complement the use of Lenacapavir in the fight against HIV/AIDS.

While new HIV infections and deaths decreased in 2023 with better access to treatment, AIDS-related deaths remain high at 630,000 and 1.3 million new infections a year.

Over 42 million people have died from AIDS since its emergence, and around 40 million people live with HIV globally, with Africa, particularly Eastern and southern regions, being the most affected.

Political decisions made this year will determine if the target to end AIDS by 2030 can be reached.

Sources: The Guardian, Forbes, O Globo, El País, Canaltech, Folha de S.Paulo, Hürriyet Daily News, Times of India, Economic Times, Mail & Guardian, Executive Digest

This article was written in collaboration with Generative AI news company Alchemiq.

Tags: HIV

Related Posts

Jannik SinnerGetty Images

World No. 1 tennis players tested positive for anabolic steroid, the results were revealed after a long delay

by Alchemiq

Despite the positive tests, an independent tribunal cleared Jannik Sinner after he successfully appealed a provisional suspension, attributing the contamination...

María Branyas Morera The Oldest woman in the world dies at 117Residencia Santa Maria del Tura/Reuters

Oldest woman in the world dies at 117

by Alchemiq

María Branyas Morera survived the COVID-19 pandemic at the age of 113 and recovered in April 2020, becoming the oldest...

Joao Felix and Conor GallagherPA/Atletico Madrid

Chelsea's frenzied transfer bout sees Conor Gallagher swapped for Joao Félix

by Alchemiq

The deal reflects Chelsea's strategy of selling homegrown players to fund new signings and rebuild their squad with young, potentially...

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il